Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SNK-396 by Synerk for Lipid Disorders: Likelihood of Approval
SNK-396 is under clinical development by Synerk and currently in Phase I for Lipid Disorders. According to GlobalData, Phase I...